Document Detail

Differential effects of p38MAP kinase inhibitors on the expression of inflammation-associated genes in primary, interleukin-1beta-stimulated human chondrocytes.
MedLine Citation:
PMID:  20590617     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: A main challenge in the therapy of osteoarthritis (OA) is the development of drugs that will modify the disease. Reliable test systems are necessary to enable an efficient screening of therapeutic substances. We therefore established a chondrocyte-based in vitro cell culture model in order to characterize different p38MAPK inhibitors.
EXPERIMENTAL APPROACH: Interleukin-1beta (IL-1beta)-stimulated human OA chondrocytes were treated with the p38MAPK inhibitors Birb 796, pamapimod, SB203580 and the new substance CBS-3868. Birb 796- and SB203580-treated cells were analysed in a genome-wide microarray analysis. The efficacy of all inhibitors was characterized by quantitative gene expression analysis and the quantification of PGE(2) and NO release.
KEY RESULTS: Microarray analysis revealed inhibitor-specific differences in gene expression. Whereas SB203580 had a broad effect on chondrocytes, Birb 796 counteracted the IL-1beta effect more specifically. All p38MAPK inhibitors significantly inhibited the IL-1beta-induced gene expression of COX-2, mPGES1, iNOS, matrix metalloproteinase 13 (MMP13) and TNFRSF11B, as well as PGE(2) release. Birb 796 and CBS-3868 showed a higher efficacy than SB203580 and pamapimod at inhibiting the expression of COX-2 and MMP13 genes, as well as PGE(2) release. In the case of mPGES1 and TNFRSF11B gene expression, CBS-3868 exceeded the efficacy of Birb 796.
CONCLUSIONS AND IMPLICATIONS: Our test system could differentially characterize inhibitors of the same primary pharmaceutical target. It reflects processes relevant in OA and is based on chondrocytes that are mainly responsible for cartilage degradation. It therefore represents a valuable tool for drug screening in between functional in vitro testing and in vivo models.
H Joos; W Albrecht; S Laufer; R E Brenner
Related Documents :
3011647 - The pro alpha 2(v) collagen gene (col5a2) maps to 2q14----2q32, syntenic to the pro alp...
15885487 - Effect of low intensity pulsed ultrasound and bmp-2 on rat bone marrow stromal cell gen...
12539557 - Molecular tissue engineering: applications for modulation of mesenchymal stem cells pro...
15389867 - A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic ...
16516917 - Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflamma...
12730377 - Reverse engineering gene networks: integrating genetic perturbations with dynamical mod...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of pharmacology     Volume:  160     ISSN:  1476-5381     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-01     Completed Date:  2010-10-07     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1252-62     Citation Subset:  IM    
Division for Biochemistry of Joint and Connective Tissue Diseases, Department of Orthopedics, University of Ulm, Ulm, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Culture Techniques
Chondrocytes / drug effects*,  metabolism*
Dinoprostone / metabolism
Drug Evaluation, Preclinical / methods*
Gene Expression / drug effects*
Inflammation Mediators / metabolism*
Interleukin-1beta / antagonists & inhibitors*,  pharmacology
Nitric Oxide / metabolism
Oligonucleotide Array Sequence Analysis / methods
Protein Kinase Inhibitors / pharmacology*
p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors*
Reg. No./Substance:
0/Inflammation Mediators; 0/Interleukin-1beta; 0/Protein Kinase Inhibitors; 10102-43-9/Nitric Oxide; 363-24-6/Dinoprostone; EC Mitogen-Activated Protein Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY72...
Next Document:  The role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditio...